Cargando…

The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018

PURPOSE: Non-communicable diseases impose a significant social, economic and health burden. Hypertension, the leading contributor to the global burden of disease and a growing public health problem worldwide, is one of the most serious non-communicable diseases. In Ethiopia, empirical evidence on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Adane, Elsabet, Atnafu, Asmamaw, Aschalew, Andualem Yalew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064277/
https://www.ncbi.nlm.nih.gov/pubmed/32184636
http://dx.doi.org/10.2147/CEOR.S234674
_version_ 1783504850545278976
author Adane, Elsabet
Atnafu, Asmamaw
Aschalew, Andualem Yalew
author_facet Adane, Elsabet
Atnafu, Asmamaw
Aschalew, Andualem Yalew
author_sort Adane, Elsabet
collection PubMed
description PURPOSE: Non-communicable diseases impose a significant social, economic and health burden. Hypertension, the leading contributor to the global burden of disease and a growing public health problem worldwide, is one of the most serious non-communicable diseases. In Ethiopia, empirical evidence on the economic burden of hypertension is limited. Therefore, this study aimed to measure the cost of hypertension and associated factors at the University of Gondar comprehensive specialized hospital, northwest Ethiopia. PATIENTS AND METHODS: An institution-based cross-sectional study was conducted on 442 adult hypertensive patients using a semi-structured questionnaire to estimate the direct and indirect costs of hypertension. The human capital approach was used to calculate indirect costs. A generalized linear model was fitted to identify factors associated with the cost of hypertension at a 95% confidence level and <0.05 p-value. RESULTS: A total of 442, 56.3% female and 64.3% stage one hypertension patients were included. The total cost of hypertension was ETB 2510.32 ($91.72) ± 2152.80 (78.65) per patient per year; The direct medical and non-medical cost constituted 60.81% and 12.17% of the total cost of hypertension, respectively. Hospitalized (exp(b)=1.87, p<0.001), using multidrug (exp(b)=1.32, p<0.000), high socioeconomic status (exp(b)=1.41,p<0.000), college and above education(exp(b)= 1.35, p<0.016), government employment (exp(b)= 1.30, p<0.012), retirement (exp(b)= 0.71, p< 0.001) and co-morbidity (exp(b)= 1.20, p<0.004) were factors significantly associated with the cost of hypertension. CONCLUSION: The total cost of illness of hypertension is high, and direct medical cost has the highest component of the total cost of illness. Hospitalization, using multidrug, co-morbidity, attending college and above education, highest socioeconomic status and government employment were factors significantly associated with the high cost of hypertension. Therefore, prevention and early detection of complications and co-morbidity are essential to reduce hospitalization and the number of drugs to reduce the direct medical and indirect costs.
format Online
Article
Text
id pubmed-7064277
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70642772020-03-17 The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018 Adane, Elsabet Atnafu, Asmamaw Aschalew, Andualem Yalew Clinicoecon Outcomes Res Original Research PURPOSE: Non-communicable diseases impose a significant social, economic and health burden. Hypertension, the leading contributor to the global burden of disease and a growing public health problem worldwide, is one of the most serious non-communicable diseases. In Ethiopia, empirical evidence on the economic burden of hypertension is limited. Therefore, this study aimed to measure the cost of hypertension and associated factors at the University of Gondar comprehensive specialized hospital, northwest Ethiopia. PATIENTS AND METHODS: An institution-based cross-sectional study was conducted on 442 adult hypertensive patients using a semi-structured questionnaire to estimate the direct and indirect costs of hypertension. The human capital approach was used to calculate indirect costs. A generalized linear model was fitted to identify factors associated with the cost of hypertension at a 95% confidence level and <0.05 p-value. RESULTS: A total of 442, 56.3% female and 64.3% stage one hypertension patients were included. The total cost of hypertension was ETB 2510.32 ($91.72) ± 2152.80 (78.65) per patient per year; The direct medical and non-medical cost constituted 60.81% and 12.17% of the total cost of hypertension, respectively. Hospitalized (exp(b)=1.87, p<0.001), using multidrug (exp(b)=1.32, p<0.000), high socioeconomic status (exp(b)=1.41,p<0.000), college and above education(exp(b)= 1.35, p<0.016), government employment (exp(b)= 1.30, p<0.012), retirement (exp(b)= 0.71, p< 0.001) and co-morbidity (exp(b)= 1.20, p<0.004) were factors significantly associated with the cost of hypertension. CONCLUSION: The total cost of illness of hypertension is high, and direct medical cost has the highest component of the total cost of illness. Hospitalization, using multidrug, co-morbidity, attending college and above education, highest socioeconomic status and government employment were factors significantly associated with the high cost of hypertension. Therefore, prevention and early detection of complications and co-morbidity are essential to reduce hospitalization and the number of drugs to reduce the direct medical and indirect costs. Dove 2020-03-06 /pmc/articles/PMC7064277/ /pubmed/32184636 http://dx.doi.org/10.2147/CEOR.S234674 Text en © 2020 Adane et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Adane, Elsabet
Atnafu, Asmamaw
Aschalew, Andualem Yalew
The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title_full The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title_fullStr The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title_full_unstemmed The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title_short The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018
title_sort cost of illness of hypertension and associated factors at the university of gondar comprehensive specialized hospital northwest ethiopia, 2018
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064277/
https://www.ncbi.nlm.nih.gov/pubmed/32184636
http://dx.doi.org/10.2147/CEOR.S234674
work_keys_str_mv AT adaneelsabet thecostofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018
AT atnafuasmamaw thecostofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018
AT aschalewandualemyalew thecostofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018
AT adaneelsabet costofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018
AT atnafuasmamaw costofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018
AT aschalewandualemyalew costofillnessofhypertensionandassociatedfactorsattheuniversityofgondarcomprehensivespecializedhospitalnorthwestethiopia2018